Pericytes are perivascular cells embedded in the basement membrane of capillaries and small vessels, playing crucial roles in blood-brain barrier maintenance, cerebral blood flow regulation, and neurovascular coupling. Pericyte loss is increasingly recognized as a key contributor to neurodegenerative disease pathogenesis, with emerging evidence suggesting that pericyte dysfunction may be among the earliest pathological changes in Alzheimer's disease and other dementias. [1]
Pericytes are mesenchymal-derived cells that wrap around capillary endothelial cells, forming an essential component of the neurovascular unit. They are essential for maintaining blood-brain barrier integrity, capillary stability, cerebral blood flow regulation, and clearance of toxic proteins. [2]
Pericytes are irregularly shaped cells with multiple processes that wrap around cerebral capillaries. Key characteristics include:
| Feature | Description |
|---|---|
| Cell body | Small, embedded in basement membrane |
| Processes | Extend along capillary axis |
| Endfoot projections | Contact endothelial cells |
| Coverage ratio | One pericyte per ~5-10 μm capillary |
Pericytes are critical for blood-brain barrier integrity through multiple mechanisms:
Pericytes regulate cerebral blood flow through neurovascular coupling:
Pericytes play crucial roles in toxic protein clearance:
Loss-of-function mutations in the PDGFRβ gene compromise pericyte survival:
Genetic variants affecting glucose transport:
APOEε4 allele carriers show enhanced pericyte vulnerability:
Reactive oxygen species damage pericytes through:
Reduced cerebral blood flow leads to:
Neuroinflammation affects pericytes via:
Pericyte loss with age represents a major risk factor:
Pericyte loss leads to catastrophic BBB breakdown:
| Consequence | Mechanism | Outcome |
|---|---|---|
| Increased permeability | Loss of tight junction regulation | Plasma protein extravasation |
| Plasma protein leakage | BBB breakdown | Perivascular edema |
| Tight junction loss | Reduced endothelial support | Increased CNS entry of toxins |
| Reduced glymphatic clearance | Impaired perivascular flow | Toxic protein accumulation |
Pericyte loss compromises hemodynamics:
Critical defects in toxic protein handling:
Pericyte loss is a hallmark of AD pathophysiology:
Pericyte dysfunction in PD vasculature:
Primary pericyte injury in vascular cognitive impairment:
Systemic effects on pericytes:
| Technique | Information | Status |
|---|---|---|
| MRI perfusion | Cerebral blood flow | Clinical |
| Dynamic contrast-enhanced MRI | BBB permeability | Clinical |
| Two-photon microscopy | Pericyte dynamics | Research |
| PET with TSPO | Neuroinflammation | Clinical |
Blood markers:
CSF markers:
| Strategy | Target | Status |
|---|---|---|
| PDGFR-β agonists | Pericyte survival | Research |
| S1P receptor modulators | Migration | Preclinical |
| VEGF modulators | Angiogenesis | Development |
| Antioxidants | Oxidative stress | Repurposed |
Pericytes show regional specialization:
Pericytes demonstrate reactive responses:
Sweeney MD, Sagare AP, Zlokovic BV. Pericytes in neurodegeneration. Nat Neurosci. 2020. ↩︎
Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown and vascular dysfunction in Alzheimer's disease. Lancet Neurol. 2021. ↩︎
Armulik et al. Pericytes regulate the blood-brain barrier (Nature, 2010). 2010. ↩︎
Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and in brain aging. Nature. 2010. ↩︎
Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014. ↩︎
Sagare AP, Bell RD, Zhao Z, et al. Pericyte Aβ clearance in Alzheimer's disease. Nat Neurosci. 2013. ↩︎
Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010. ↩︎
Bell RD, Winkler EA, Singh I, et al. APOE4 vascular dysfunction and impaired neuronal coactivator PGC-1α in Alzheimer's disease. Nat Neurosci. 2018. ↩︎
Chen Y, Liu Y, Gulbranson DR, et al. Capillary pericytes mediate the neurovascular unit in the aged brain. Aging Cell. 2019. ↩︎
Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to Alzheimer's disease neurovascular dysfunction. Nat Rev Neurosci. 2019. ↩︎
Zhou W, Xu D, Peng C, et al. Pericyte clearance of tau in Alzheimer's disease. Acta Neuropathol. 2021. ↩︎
Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytes in health and disease. Nat Rev Neurosci. 2014. ↩︎
Iannucci J, Vides R, Kamble N, et al. Pericyte dysfunction in Parkinson's disease. Mov Disord. 2020. ↩︎
Ward M, McCarthy C, McClearn C, et al. Vascular dementia and pericytes. J Cereb Blood Flow Metab. 2021. ↩︎
Beltramo E, Porta M. Diabetic microangiopathy: pericyte loss and its implications. Diabetologia. 2019. ↩︎
Montagne A, Zhao Z, Zlokovic BV. Blood biomarkers for blood-brain barrier dysfunction. Nat Rev Neurol. 2022. ↩︎
Zlokovic BV, Apte RS. Therapeutic targeting of neurovascular dysfunction in neurodegenerative disease. Nat Rev Drug Discov. 2021. ↩︎
Nakagawa H, Takemura Y, Shibata M, et al. Pericyte regeneration strategies for brain vascular repair. Stem Cell Reports. 2020. ↩︎